Intravenous combined with nebulized polymyxin B may be effective in treating carbapenem-resistant gram-negative bacilli hospital-acquired pneumonia: a retrospective cohort study.

[ 26 ] demonstrated better microbial clearance and reduced mortality in VAP patients with multidrug-resistant Klebsiella pneumoniae when treated with both intravenous and nebulized polymyxin B compared to intravenous polymyxin B alone, but these improvements did not reach statistical significance.

also in 111,027 other papers